Stock 1672 ASCLETIS PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Ascletis Pharma Inc.

Equities

1672

KYG0520K1094

Delayed Hong Kong S.E.
Other stock markets
 10:16:59 2024-05-01 pm EDT 		5-day change 1st Jan Change
1.33 HKD +2.31% Intraday chart for Ascletis Pharma Inc. +4.72% -8.90%
Apr. 03 Ascletis Discontinues Trials of FXR Agonist for Biliary Cholangitis, NASH and Hepatitis B Virus MT
Apr. 03 Ascletis Pharma Inc. Announces Strategic Decisions on FXR Agonist ASC42 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ascletis Pharma Inc. Appoints John P. Gargiulo as Chief Business Officer
CI
Ascletis Pharma Inc. Announces Board Changes
CI
Ascletis Pharma Inc. Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer
CI
Ascletis Pharma Inc. Announces the Resignation of Joint Company Secretary and Change of Authorized Representative
CI
Ascletis Pharma Inc. Appoints Zhengqing Li as Chief Medical Officer and President of R&D Greater China
CI
Ascletis Pharma Announces Resignation of Wei Fu as Non-Executive Director
CI
Ascletis Pharma Inc. Appoints Dr. Lindi Tan as Chief Financial Officer
CI
Ascletis Pharma Inc. Appoints Joshua Zhongbao Ling as Vice President of Finance
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1672 Stock
  4. News Ascletis Pharma Inc.
  5. Insiders